Regulation of Smad degradation and activity by Smurf2, an E3 ubiquitin ligase

被引:415
作者
Zhang, Y [1 ]
Chang, CB
Gehling, DJ
Hemmati-Brivanlou, A
Delynck, R
机构
[1] NCI, Cellular & Mol Biol Lab, Div Basic Sci, Bethesda, MD 20892 USA
[2] Univ Calif San Francisco, Dept Growth & Dev, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA
[4] Univ Calif San Francisco, Cell Biol Program, San Francisco, CA 94143 USA
[5] Univ Calif San Francisco, Program Dev Biol, San Francisco, CA 94143 USA
[6] Rockefeller Univ, Mol Embryol Lab, New York, NY 10021 USA
关键词
D O I
10.1073/pnas.98.3.974
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Smad proteins are key intracellular signaling effecters for the transforming growth factor-beta superfamily of peptide growth factors. Following receptor-induced activation, Smads move into the nucleus to activate transcription of a select set of target genes. The activity of Smad proteins must be tightly regulated to exert the biological effects of different ligands in a timely manner. Here, we report the identification of Smurf2, a new member of the Hect family of E3 ubiquitin ligases. Smurf2 selectively interacts with receptor-regulated Smads and preferentially targets Smad1 for ubiquitination and proteasome-mediated degradation. At higher expression levels, Smurf2 also decreases the protein levels of Smad2, but not Smad3. In Xenopus embryos, ectopic Smurf2 expression specifically inhibits Smad1 responses and thereby affects embryonic patterning by bone morphogenetic protein signals. These findings suggest that Smurf2 may regulate the competence of a cell to respond to transforming growth factor-beta /bone morphogenetic protein signaling through a distinct degradation pathway that is similar to, yet independent of, Smurf1.
引用
收藏
页码:974 / 979
页数:6
相关论文
共 36 条
[1]   A novel mesoderm inducer, Madr2 functions in the activin signal transduction pathway [J].
Baker, JC ;
Harland, RM .
GENES & DEVELOPMENT, 1996, 10 (15) :1880-1889
[2]  
Candia AF, 1997, DEVELOPMENT, V124, P4467
[3]   Smads:: Transcriptional activators of TGF-β responses [J].
Derynck, R ;
Zhang, Y ;
Feng, XH .
CELL, 1998, 95 (06) :737-740
[4]  
Derynck Rik, 1998, P593
[5]   The tumor suppressor Smad4/DPC4 and transcriptional adaptor CBP/p300 are coactivators for Smad3 in TGF-β-induced transcriptional activation [J].
Feng, XH ;
Zhang, Y ;
Wu, RY ;
Derynck, R .
GENES & DEVELOPMENT, 1998, 12 (14) :2153-2163
[6]   Xenopus Mad proteins transduce distinct subsets of signals for the TGF beta superfamily [J].
Graff, JM ;
Bansal, A ;
Melton, DA .
CELL, 1996, 85 (04) :479-487
[7]   HUMAN TRANSFORMING GROWTH FACTOR-BETA-3 - RECOMBINANT EXPRESSION, PURIFICATION, AND BIOLOGICAL-ACTIVITIES IN COMPARISON WITH TRANSFORMING GROWTH FACTOR-BETA-1 AND FACTOR-BETA-2 [J].
GRAYCAR, JL ;
MILLER, DA ;
ARRICK, BA ;
LYONS, RM ;
MOSES, HL ;
DERYNCK, R .
MOLECULAR ENDOCRINOLOGY, 1989, 3 (12) :1977-1986
[8]   CDI1, A HUMAN G1-PHASE AND S-PHASE PROTEIN PHOSPHATASE THAT ASSOCIATES WITH CDK2 [J].
GYURIS, J ;
GOLEMIS, E ;
CHERTKOV, H ;
BRENT, R .
CELL, 1993, 75 (04) :791-803
[9]  
HARLAND RM, 1991, METHOD CELL BIOL, V36, P685
[10]   Smad6 inhibits BMP/Smad1 signaling by specifically competing with the Smad4 tumor suppressor [J].
Hata, A ;
Lagna, G ;
Massagué, J ;
Hemmati-Brivanlou, A .
GENES & DEVELOPMENT, 1998, 12 (02) :186-197